FX & CFD trading involves significant risk
European stocks climbed resuming trading after Easter holidays. The key driver of the increase was a deal between GlaxoSmithKline Plc and Novartis AG. Novartis AG agreed to buy Glaxo’s cancer-drug business.
Focus continues on tensions in Ukraine.
GlaxoSmithKline Plc climbed 5.4%. Novartis AG shares rose 2.5%.
AstraZeneca shares increased 7.8%, caused by rumours about a potential AstraZeneca acquisition by Pfizer.
Philips shares dropped 6.6% after the publication of the weak first quarter results.
Name Price Change Change %
FTSE 100 6,691.32 66.01 1.00%
DAX 9,527.97 118.26 1.26%
CAC 40 4,470.28 38.47 0.87%
All posted material is a marketing communication solely for informational purposes and reliance on this may lead to loss. Past performance is not a reliable indicator of future results. Please read our full disclaimer.